Compared side by side

CJC-1295 no DAC vs sermorelin: how they differ

Reviewed How we check the libraryPublished by PepVault

The short answer

Both are GHRH analogues that give short, pulse-like GH release: sermorelin is the unmodified first 29 amino acids of GHRH, with a half-life of about 11–12 minutes, and CJC-1295 no DAC (also sold as Mod GRF 1-29) is a modified form of the same chain whose half-life in people hasn’t been measured. Sermorelin is taken once a day before bed, CJC-1295 no DAC 2–3 times a day, usually with ipamorelin. Sermorelin was FDA-approved until its maker discontinued it in 2008; the no-DAC form has no published human studies.

Side by side

ComparedCJC-1295 no DACSermorelin
CategoryGrowth hormoneGrowth hormone
Also known asModified GRF 1-29, Mod GRF 1-29, CJC-1295 without DACGHRH 1-29, GRF 1-29
What it isThe shorter-acting version of CJC-1295, meant to give sharp, pulse-like GH release.A synthetic copy of the first 29 amino acids of your natural growth hormone releasing hormone: it prompts your pituitary to release its own GH, keeping the body's feedback loops in play.
How it worksGHRH analogue without the DAC modification. Its half-life in people hasn't been measured (native GHRH lasts minutes), and the short action gives pulse-like GH release. Usually stacked with Ipamorelin to mimic natural GH secretion patterns.Synthetic analogue of endogenous GHRH. Stimulates the pituitary to produce and secrete GH naturally. Considered a more physiological approach to GH optimization compared to exogenous GH.
Commonly reportedA flush or head rush within minutes of injecting, deeper sleep and vivid dreams early on, and mild water retention over the weeks. The no-DAC form itself has no published human studies.Deeper sleep and vivid dreams in the first weeks, with gentle, slow-building effects, milder than CJC/ipamorelin. It was FDA-approved as a diagnostic test (1990) and to treat GH deficiency in children (1997) until the maker discontinued it in 2008, not for safety reasons.
Studied rangeResearch range: 100–200 mcg. Studied in research — not a recommendation.Research range: 200–500 mcg, starting dose 200 mcg. Studied in research — not a recommendation.
How often2–3x dailyDaily, before bed
Half-life~30 min (community estimate; not measured in people: sermorelin, the unmodified 1-29 chain, lasts 11–12 minutes)~11–12 min (US Geref label, after IV or SubQ)
RouteSubQ injectionSubQ injection
Typical run8–12 weeks typical. Usually stacked with Ipamorelin; cycle both together.3–6 months common; considered a more physiological approach so longer cycles are used.
EvidenceModerate: animal studies + some human dataEstablished: clinical trials or FDA-approved use exists
Common side effectsWater retention, headache, flushing, injection site painHeadache, flushing, dizziness, nausea, injection site reaction, water retention

Typical run: Community practice — opinions vary. Not a clinical recommendation.

A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Taking CJC-1295 no DAC or sermorelin? Log it in PepVault

Each dose, each vial and your step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Week by week

Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.

CJC-1295 no DAC

  • Day 1–14 Sleep usually moves first
  • Day 14–28 Recovery is quicker, skin looks better
  • Day 28–56 Body composition starts shifting
  • Day 56–84 Cycle endpoint

Every card for CJC-1295 no DAC, with its sources

Sermorelin

  • Day 1–14 Sleep is the first signal
  • Day 14–42 Recovery and skin are responding
  • Day 42–180 The long game is paying off

Every card for sermorelin, with its sources

Together or one or the other

CJC-1295 no DAC and sermorelin are a common stack: CJC-1295 no DAC lists sermorelin among its common stacks.

Questions people ask

How long do CJC-1295 no DAC and sermorelin last?

The half-life of CJC-1295 no DAC is ~30 min (community estimate; not measured in people: sermorelin, the unmodified 1-29 chain, lasts 11–12 minutes). The half-life of sermorelin is ~11–12 min (US Geref label, after IV or SubQ).

How often are CJC-1295 no DAC and sermorelin taken?

CJC-1295 no DAC: 2–3x daily. Route: SubQ injection. Sermorelin: daily, before bed. Route: SubQ injection.

How are CJC-1295 no DAC and sermorelin dosed in research?

The research range for CJC-1295 no DAC is 100–200 mcg. The research range for sermorelin is 200–500 mcg, with a 200 mcg starting dose. Studied in research — not a recommendation.

What are the common side effects of CJC-1295 no DAC and sermorelin?

For CJC-1295 no DAC, the library lists: water retention, headache, flushing, injection site pain. For sermorelin: headache, flushing, dizziness, nausea, injection site reaction, water retention.

Are CJC-1295 no DAC and sermorelin taken together?

CJC-1295 no DAC and sermorelin are a common stack: CJC-1295 no DAC lists sermorelin among its common stacks.

Each one in full

Track it in the app

PepVault for iPhone

Taking CJC-1295 no DAC or sermorelin? Log it in PepVault

Each dose, each vial and your step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo